Ispor25

After Modelling and Regulations & Pricing, and just a few days before ISPOR25, here is my take on the potentially interesting sessions on Artificial Intelligence (AI, which generally means: the use of Generative AI, or GenAI, in HEOR). First, Sven Klijn, William Rawlinson, and Tim Reason are again offering their introductory course on Applied Generative AI for HEOR. Last year, I followed it in Barcelona, and it was nice. In my opinion, “nice” means that although I didn’t learn much more than previous presentations by the authors and my own experience, it was a great course for beginners because it struck the right balance between theory (which too many sessions end up only covering) and practical examples. Don’t expect hands-on exercises (that would be too long, and the course synopsis doesn’t mention that either). But “nice” to me means that the presenters dared to show actual working code, with all the humility that it implies. This year, they mention they’ll cover Retrieval-Augmented Generation (RAG) and agents. Hopefully, their coverage of these aspects will be as good as last year’s on the other topics. ...

ISPOR 2025 is now in about two weeks and in this second post about sessions to look for, I’ll talk about regulations and pricing (this is part of a series: last week, I wrote about Modelling; next week, I will write about AI). IRA letters on a pile of scientific papers with a view of an American city at night ...

ISPOR25, the annual North American conference for the International Society for Pharmacoeconomics and Outcomes Research, is in three weeks. As usual, I’m planning for it by browsing its program. This time, I decided to share a few of my interests on my blog. ISPOR usually covers many topics, from “hardcore” statistical methods to top-level overviews of some issues, so I will focus on only a few topics. Feel free to connect with me if you want to discuss anything at or around the conference (or virtually). (And before we start, full disclaimer: I’m currently working for Parexel, but opinions shared here are only mine; otherwise, I would have written them on the company blog.) ...